Sabrina H. van Ierssel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sabrina H. van Ierssel has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Andrew I.R. Maas
Department of Neurosurgery Antwerp University Hospital, University of Antwerp Edegem Belgium
1 shared publicationChristiaan J. Vrints
Laboratory of Cellular and Molecular Cardiology Antwerp University Hospital, University of Antwerp Edegem Belgium
1 shared publicationEmeline M. Van Craenenbroeck
Laboratory of Cellular and Molecular Cardiology Antwerp University Hospital, University of Antwerp Edegem Belgium
1 shared publication- Paul Maria Parizel
National Imaging Facility, Centre for Microscopy Characterisation and Analysis, The University of Western Australia, Perth, WA, Australia
1 shared publication Philippe G. Jorens
Department of Critical Care Medicine Antwerp University Hospital, University of Antwerp Edegem Belgium
1 shared publicationVicky Y. Hoymans
Laboratory of Cellular and Molecular Cardiology Antwerp University Hospital, University of Antwerp Edegem Belgium
1 shared publication
Latest Publications
- Open Access
- 9 February 2015
- Published by Wiley in Journal of Neuroscience Research
- Vol. 93 (6) , 866-872
Endothelial dysfunction in acute brain injury and the development of cerebral ischemia
Cerebral ischemia (CeI) is a major complicating event after acute brain injury (ABI) in which endothelial dysfunction is a key player. This study evaluates cellular markers of endothelial function and in vivo reactive hyperemia in patients with ABI and their relationship to the development of cerebral ischemia. We studied cellular markers of endothelial dysfunction and the peripheral reactive hyperemia index (RHI) in 26 patients with ABI at admission and after 6 and 12 days, and compared these with those of healthy volunteers (n = 15). CeI was determined clinically or by computer tomography. In patients with ABI, RHI at admission was significantly reduced compared with healthy subjects (P = 0.003), coinciding with a decrease in circulating endothelial progenitor cells (EPC; P = 0.002). The RHI recovered in eight patients without development of CeI, but failed to fully recover by day 12 in three of four patients who developed CeI. Despite recovery of the RHI within 12 days in these patients (P = 0.003), EPC count remained significantly lower after 12 days in patients with ABI (P = 0.022). CD31+ T cells and endothelial microparticles were not different between controls and patients. No differences were noted in cellular markers of endothelial dysfunction in patients developing CeI and those not. In conclusion, patients with ABI exhibit impaired microvascular endothelial function measured as RHI and a decreased circulating level of EPC.
- 9 February 2015
- Published by Wiley in Journal of Neuroscience Research
- Vol. 93 (6) , 866-872
Open AccessEndothelial dysfunction in acute brain injury and the development of cerebral ischemia
Cerebral ischemia (CeI) is a major complicating event after acute brain injury (ABI) in which endothelial dysfunction is a key player. This study evaluates cellular markers of endothelial function and in vivo reactive hyperemia in patients with ABI and their relationship to the development of cerebral ischemia. We studied cellular markers of endothelial dysfunction and the peripheral reactive hyperemia index (RHI) in 26 patients with ABI at admission and after 6 and 12 days, and compared these with those of healthy volunteers (n = 15). CeI was determined clinically or by computer tomography. In patients with ABI, RHI at admission was significantly reduced compared with healthy subjects (P = 0.003), coinciding with a decrease in circulating endothelial progenitor cells (EPC; P = 0.002). The RHI recovered in eight patients without development of CeI, but failed to fully recover by day 12 in three of four patients who developed CeI. Despite recovery of the RHI within 12 days in these patients (P = 0.003), EPC count remained significantly lower after 12 days in patients with ABI (P = 0.022). CD31+ T cells and endothelial microparticles were not different between controls and patients. No differences were noted in cellular markers of endothelial dysfunction in patients developing CeI and those not. In conclusion, patients with ABI exhibit impaired microvascular endothelial function measured as RHI and a decreased circulating level of EPC.